Increase of 3-methoxy-4-hydroxyphenylethylene glycol in rat brain by neuroleptic drugs.
D000818:Animals; D001923:Brain Chemistry / Q000187:drug effects*; D002746:Chlorpromazine / Q000494:pharmacology; D003984:Dibenzazepines / Q000494:pharmacology; D003988:Dibenzothiepins / Q000494:pharmacology; D004305:Dose-Response Relationship, Drug; D006018:Glycols / Q000378:metabolism*; D006220:Haloperidol / Q000494:pharmacology; D008297:Male; D008734:Methoxyhydroxyphenylglycol / Q000378:metabolism; D010868:Pimozide / Q000494:pharmacology; D010879:Piperazines / Q000494:pharmacology; D051381:Rats; D013440:Sulfides / Q000494:pharmacology; D013881:Thioridazine / Q000494:pharmacology; D014149:Tranquilizing Agents / Q000494:pharmacology*
D003984:Dibenzazepines; D003988:Dibenzothiepins; D006018:Glycols; D010879:Piperazines; D013440:Sulfides; D014149:Tranquilizing Agents; D010868:Pimozide; D008734:Methoxyhydroxyphenylglycol; D006220:Haloperidol; D013881:Thioridazine; D002746:Chlorpromazine